News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
364,076 Results
Type
Article (14432)
Company Profile (114)
Press Release (349530)
Section
Business (112622)
Career Advice (456)
Deals (18610)
Drug Delivery (28)
Drug Development (31172)
Employer Resources (50)
FDA (8792)
Job Trends (7672)
News (172737)
Policy (12355)
Tag
2024 BioCapital Digital (1)
2024 BioForest Digital (6)
2024 BioMidwest Digital (1)
2024 Bio NC Digital (4)
2024 Bio NC Standard (2)
2024 Biotech Bay Standard (8)
2024 Biotech Beach Digital (2)
2024 Biotech Beach Standard (3)
2024 Genetown Digital (1)
2024 Genetown Standard (6)
2024 Lone Star Bio Digital (4)
2024 Pharm Country Digital (3)
2024 Pharm Country Standard (2)
2025 Lone Star Bio Digital (3)
2026 BioCapital Elite (1)
2026 Biotech Bay Standard (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1320)
Allergies (39)
Alliances (34771)
ALS (22)
Alzheimer's disease (504)
Antibody-drug conjugate (ADC) (62)
Approvals (8812)
Artificial intelligence (226)
Autoimmune disease (2)
Automation (11)
Bankruptcy (131)
Best Places to Work (6522)
BIOSECURE Act (6)
Biosimilars (9)
Biotechnology (86)
Bladder cancer (21)
Brain cancer (11)
Breast cancer (108)
Cancer (947)
Cardiovascular disease (60)
Career advice (406)
Career pathing (8)
CAR-T (97)
Cell therapy (256)
Cervical cancer (10)
Clinical research (24425)
Collaboration (566)
Compensation (103)
Complete response letters (3)
COVID-19 (1146)
CRISPR (34)
C-suite (131)
Cystic fibrosis (47)
Data (909)
Decentralized trials (1)
Denatured (18)
Depression (16)
Diabetes (93)
Diagnostics (4898)
Digital health (15)
Diversity (4)
Diversity, equity & inclusion (9)
Drug discovery (73)
Drug pricing (13)
Drug shortages (4)
Duchenne muscular dystrophy (19)
Earnings (38568)
Editorial (2)
Employer branding (8)
Employer resources (43)
Events (51125)
Executive appointments (362)
FDA (9365)
Featured Employer (25)
Fibrodysplasia Ossificans Progressiva (1)
Frontotemporal dementia (1)
Funding (446)
Gene editing (80)
Generative AI (23)
Gene therapy (161)
GLP-1 (222)
Government (1232)
Grass and pollen (2)
Guidances (23)
Healthcare (9891)
Huntington's disease (5)
IgA nephropathy (10)
Immunology and inflammation (28)
Indications (11)
Infectious disease (1217)
Inflammatory bowel disease (60)
Inflation Reduction Act (3)
Influenza (31)
Intellectual property (57)
Interviews (51)
IPO (8002)
IRA (8)
Job creations (1434)
Job search strategy (362)
Kidney cancer (3)
Labor market (9)
Layoffs (115)
Leadership (3)
Legal (2520)
Liver cancer (34)
Lung cancer (120)
Lymphoma (56)
Machine learning (2)
Management (17)
Manufacturing (167)
MASH (15)
Medical device (11453)
Medtech (11458)
Mergers & acquisitions (10932)
Metabolic disorders (201)
Multiple sclerosis (24)
NASH (3)
Neurodegenerative disease (27)
Neuropsychiatric disorders (3)
Neuroscience (681)
NextGen: Class of 2025 (3535)
Non-profit (1519)
Northern California (1025)
Now hiring (8)
Obesity (86)
Opinion (75)
Ovarian cancer (39)
Pain (46)
Pancreatic cancer (38)
Parkinson's disease (62)
Partnered (11)
Patents (129)
Patient recruitment (48)
Peanut (26)
People (32677)
Pharmaceutical (16)
Phase I (9009)
Phase II (11021)
Phase III (7152)
Pipeline (498)
Podcasts (37)
Policy (27)
Postmarket research (501)
Preclinical (4064)
Press Release (66)
Prostate cancer (39)
Psychedelics (4)
Radiopharmaceuticals (155)
Rare diseases (130)
Real estate (3358)
Recruiting (20)
Regulatory (9330)
Reports (18)
Research institute (1269)
Resumes & cover letters (68)
Rett syndrome (2)
RNA editing (2)
RSV (21)
Schizophrenia (11)
Series A (81)
Series B (48)
Service/supplier (7)
Sickle cell disease (17)
Southern California (1116)
Special edition (1)
Spinal muscular atrophy (58)
Sponsored (13)
Startups (2505)
State (2)
Stomach cancer (2)
Supply chain (22)
The Weekly (18)
United States (10802)
Vaccines (309)
Venture capitalists (19)
Webinars (7)
Weight loss (34)
Women's health (17)
Worklife (2)
Date
Today (75)
Last 7 days (318)
Last 30 days (1380)
Last 365 days (17724)
2025 (4207)
2024 (18710)
2023 (22098)
2022 (30813)
2021 (32513)
2020 (30537)
2019 (25793)
2018 (19458)
2017 (18871)
2016 (17761)
2015 (20560)
2014 (15177)
2013 (12742)
2012 (13781)
2011 (14066)
2010 (12826)
Location
Africa (318)
Alabama (37)
Alaska (6)
Arizona (119)
Arkansas (10)
Asia (24001)
Australia (4178)
California (2684)
Canada (983)
China (227)
Colorado (154)
Connecticut (126)
Delaware (38)
Europe (49031)
Florida (443)
Georgia (131)
Idaho (33)
Illinois (265)
India (10)
Indiana (152)
Iowa (4)
Japan (100)
Kansas (80)
Kentucky (6)
Louisiana (5)
Maine (20)
Maryland (432)
Massachusetts (1886)
Michigan (179)
Minnesota (240)
Mississippi (2)
Missouri (56)
Montana (24)
Nebraska (15)
Nevada (19)
New Hampshire (66)
New Jersey (849)
New Mexico (16)
New York (800)
North Carolina (503)
North Dakota (7)
Northern California (1025)
Ohio (99)
Oklahoma (11)
Oregon (19)
Pennsylvania (553)
Puerto Rico (7)
Rhode Island (20)
South America (505)
South Carolina (16)
South Dakota (1)
Southern California (1116)
Tennessee (54)
Texas (435)
Utah (99)
Virginia (52)
Washington D.C. (11)
Washington State (311)
West Virginia (3)
Wisconsin (35)
364,076 Results for "mirion technologies".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Press Releases
Mirion to Elevate Radiopharmaceutical Production Quality with Advanced Apex-Guard Software
April 2, 2025
·
3 min read
Deals
Mirion Announces Completion of Redemption of its Outstanding Public Warrants
Mirion today announced that it completed the redemption of its outstanding publicly traded warrants (the “Public Warrants”) to purchase shares of the Company’s common stock.
May 23, 2024
·
4 min read
Mirion to Present at Jefferies’ 2024 Global Healthcare Conference
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Jefferies’ 2024 Global Healthcare Conference in New York, NY. The presentation will begin at 4:00 PM ET on Thursday, June 6, 2024.
May 23, 2024
·
1 min read
Press Releases
Mirion to Detail Financial Targets and Long-term Strategy at Today’s Investor Day
December 3, 2024
·
13 min read
Business
Mirion Announces Earnings Release and Conference Call Date for First Quarter 2024
Mirion (NYSE: MIR) announced today that it will release financial results for first quarter 2024 after market close on Tuesday, April 30, 2024.
April 17, 2024
·
1 min read
Business
Mirion Announces First Quarter 2024 Financial Results and Reaffirms Full Year Guidance
Mirion, a global provider of radiation detection, measurement, analysis and monitoring solutions to the medical, nuclear, defense, and research end markets, announced results for the first quarter ended March 31, 2024.
April 30, 2024
·
21 min read
Mirion to Present at B. Riley Securities’ Radiopharma Day
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, will present at B. Riley Securities’ Radiopharma Day in New York, NY.
February 22, 2024
·
1 min read
BioMidwest
Mirion Technologies Gamma Detector to Play Crucial Role in NASA’s Psyche Mission
Mirion Technologies, a leading provider of advanced radiation safety solutions, announced its contribution to the Psyche mission, which launched from the agency’s Kennedy Space Center in Florida on October 13, 2023.
October 16, 2023
·
2 min read
Mirion to Present at Citi’s 2024 Global Industrial Tech and Mobility Conference
Mirion (NYSE: MIR) announced today that Chief Executive Officer, Thomas Logan, and Chief Financial Officer, Brian Schopfer, will present at Citi’s 2024 Global Industrial Tech and Mobility Conference in Miami, FL.
February 12, 2024
·
1 min read
BioMidwest
Mirion Technologies Announces Pricing of Public Offering by Selling Stockholders
Mirion Technologies, Inc. announced the pricing of an underwritten public offering of 7,000,000 shares of Mirion’s Class A common stock by certain selling stockholders at a price to the public of $7.65 per share.
May 12, 2023
·
3 min read
1 of 36,408
Next
